Skip to main content
EVEX
NYSE Manufacturing

Eve Holding Reports Widened Q1 Loss Amid Increased R&D and Significant Debt Inflow

Analysis by Arik Shkolnikov
Sentiment info
Negative
Importance info
7
Price
$2.875
Mkt Cap
$992.668M
52W Low
$2.34
52W High
$7.699
Market data snapshot near publication time

summarizeSummary

Eve Holding reported a Q1 2026 net loss of $(68.8) million, a 41% increase from the prior year, driven by higher R&D. The company secured $167.9 million in new debt, bringing total liquidity to $578 million, deemed sufficient for the next 12 months, despite a notable decline in total equity.


check_boxKey Events

  • Net Loss Widens Significantly

    The company reported a net loss of $(68.8) million for Q1 2026, a 41% increase from $(48.8) million in Q1 2025, primarily due to increased R&D expenses.

  • Increased R&D Investment

    Research and development expenses rose by $14.4 million (32%) to $59.1 million, reflecting intensified eVTOL development activities and flight testing.

  • Substantial Debt Financing Secured

    Long-term debt increased by $119.4 million to $295.8 million, with $150 million drawn from a new syndicated credit agreement and $13.6 million from a PEFCO/US EXIM loan.

  • Liquidity Position Updated

    Total liquidity, including cash, financial investments, available debt, and grant funding, stands at approximately $578 million, projected to fund operations for at least the next twelve months.


auto_awesomeAnalysis

Eve Holding's Q1 2026 results show a significant widening of its net loss to $(68.8) million, a 41% increase year-over-year, driven by intensified research and development efforts for its eVTOL project. While the company continues to operate without revenue, it has successfully secured substantial financing, increasing long-term debt by $119.4 million to $295.8 million, including a new $150 million syndicated credit agreement. This capital, combined with existing cash and grants, provides approximately $578 million in total liquidity, which management states is sufficient for at least the next twelve months. However, total equity declined significantly due to the accumulated deficit. An ongoing shareholder derivative action related to a 2024 private placement also continues, with a new schedule set for amended complaints and responses.

At the time of this filing, EVEX was trading at $2.88 on NYSE in the Manufacturing sector, with a market capitalization of approximately $992.7M. The 52-week trading range was $2.34 to $7.70. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed EVEX - Latest Insights

EVEX
May 05, 2026, 6:11 AM EDT
Source: Wiseek News
Importance Score:
7
EVEX
May 05, 2026, 6:03 AM EDT
Filing Type: 8-K
Importance Score:
8
EVEX
May 05, 2026, 6:02 AM EDT
Filing Type: 10-Q
Importance Score:
7
EVEX
Apr 09, 2026, 4:17 PM EDT
Filing Type: DEF 14A
Importance Score:
8
EVEX
Mar 16, 2026, 4:02 PM EDT
Filing Type: 8-K
Importance Score:
8
EVEX
Mar 16, 2026, 4:01 PM EDT
Filing Type: 10-K
Importance Score:
8
EVEX
Jan 29, 2026, 5:25 PM EST
Filing Type: 8-K
Importance Score:
7
EVEX
Jan 16, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
8